Cargando…
A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539947/ https://www.ncbi.nlm.nih.gov/pubmed/32602177 http://dx.doi.org/10.1002/ajh.25920 |
| _version_ | 1783591119642165248 |
|---|---|
| author | Achebe, Maureen M. Glaspy, John Kalra, Philip A. Auerbach, Michael Thomsen, Lars L. Bhandari, Sunil |
| author_facet | Achebe, Maureen M. Glaspy, John Kalra, Philip A. Auerbach, Michael Thomsen, Lars L. Bhandari, Sunil |
| author_sort | Achebe, Maureen M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7539947 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75399472020-10-09 A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial Achebe, Maureen M. Glaspy, John Kalra, Philip A. Auerbach, Michael Thomsen, Lars L. Bhandari, Sunil Am J Hematol Correspondence John Wiley & Sons, Inc. 2020-07-31 2020-10 /pmc/articles/PMC7539947/ /pubmed/32602177 http://dx.doi.org/10.1002/ajh.25920 Text en © 2020 The Authors. American Journal of Hematology published by Wiley Periodicals LLC. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondence Achebe, Maureen M. Glaspy, John Kalra, Philip A. Auerbach, Michael Thomsen, Lars L. Bhandari, Sunil A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial |
| title | A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial |
| title_full | A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial |
| title_fullStr | A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial |
| title_full_unstemmed | A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial |
| title_short | A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial |
| title_sort | 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: the ferwon‐ext trial |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539947/ https://www.ncbi.nlm.nih.gov/pubmed/32602177 http://dx.doi.org/10.1002/ajh.25920 |
| work_keys_str_mv | AT achebemaureenm a6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial AT glaspyjohn a6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial AT kalraphilipa a6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial AT auerbachmichael a6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial AT thomsenlarsl a6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial AT bhandarisunil a6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial AT achebemaureenm 6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial AT glaspyjohn 6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial AT kalraphilipa 6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial AT auerbachmichael 6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial AT thomsenlarsl 6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial AT bhandarisunil 6monthextensiontrialevaluatingsafetyandefficacyofferricderisomaltoseinpatientswithirondeficiencyanemiatheferwonexttrial |